IP Library Granted Patent US 9,529,005
Granted Patent B2
US 9,529,005 · App. 14/861,709 · Granted Dec 27, 2016

Modulating bacterial MAM polypeptides in pathogenic disease

Inventors: Kim Orth (Dallas, TX); Hyeilin Ham (Dallas, TX); Anne-Marie Krachler (Malvern, GB)
Assignee: The Board of Regents of the University of Texas System
G01N33/92A23L33/135A61K35/74A61K35/741A61K38/164G01N33/554G01N33/56911G01N2333/195
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,529,005
App. No.
14/861,709
Granted
Dec 27, 2016
Kind
B2
Abstract

The present invention relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a MAM polypeptide by administering to a subject a composition comprising a MAM polypeptide or a non-pathogenic bacterium expressing a MAM polypeptide, or a combination thereof.

Claims (9)

1. A method for identifying or quantifying protein-lipid interaction on a membrane comprising contacting a membrane with a peptide or polypeptide comprising multivalent adhesion molecule (MAM) mce repeat region.

2. The method of claim 1 , wherein said peptide comprises 1, 2, 3, 4, 5, 6 or 7 mce repeat regions.

3. The method of claim 1 , wherein said peptide or polypeptide is labeled.

4. The method of claim 3 , wherein said label is a fluorescent label, a chemilluminscent label, and enzyme label, a dye, a colorimetric label, a quantum dot, or a ligand.

5. The method of claim 1 , wherein said membrane is part of an intact cell.

6. The method of claim 5 , wherein said cell is a fixed cell.

7. The method of claim 5 , wherein said cell is a living cell.

8. The method of claim 7 , wherein said cell has been treated with an agent.

9. The method of claim 8 , further comprising the step, prior to treatment with said agent, of identifying or quantifying lipid on said cell's membrane.

Assignments (1)
CONFIRMATORY LICENSE Recorded Apr 4, 2022
From: UT SOUTHWESTERN MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 059581/0433 →
Continuity (3)
Continuation 14009724
Provisional Application 61472440 · Apr 6, 2011
Related Publication 20160169921A1 · Jun 16, 2016